Hyperkalemia Quality Improvement Program (HK-QIP) Study

NARecruitingINTERVENTIONAL
Enrollment

1,000

Participants

Timeline

Start Date

June 25, 2025

Primary Completion Date

December 11, 2027

Study Completion Date

December 11, 2027

Conditions
Hyperkalemia Patient With Non-Dialysis Chronic Kidney Disease
Interventions
OTHER

standard hyperkalemia management implementation

The interventions include HK disease management and quality audits for health care professionals (HCPs) and patients (Figure 1). The main contents of HK disease management in CKD include a standardized clinical pathway based on guideline adoption and medical trainings to educate HCPs and patients.

Trial Locations (1)

200032

RECRUITING

Research Site, Shanghai

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY